Algorae Pharmaceuticals Limited
1AI
Classement en actions
#30925
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Prix de l'action
$0.00705285
Capitalisation boursière
$14.30M
Changement (1 jour)
0.00%
Changement (1 an)
-30.71%
Pays
AU
Échange Algorae Pharmaceuticals Limited (1AI)
Catégorie
Healthcare
Capitalisation boursière de Algorae Pharmaceuticals Limited(1AI)
Capitalisation boursière: $14.30M
En October 2026, Algorae Pharmaceuticals Limited a une capitalisation boursière de $14.30M. Cela fait de Algorae Pharmaceuticals Limited la 30925th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Algorae Pharmaceuticals Limited du 2004 au 2026
1AI par rapport au top 5 des plus populaires stocks
